PH willing to join clinical trials for COVID-19 drug
MANILA, Philippines — The Philippines is ready to participate in clinical trials of potential COVID-19 vaccines like Avigan, Cabinet Secretary Karlo Nograles said, quoting President Rodrigo Duterte’s exchange with Japanese Prime Minister Shinzo Abe during the Association of Southeast Asian Nations (Asean) Summit with Japan, South Korea and China on Monday.
In a recent report to Congress, the President said the health department was considering the use of the anti-flu drug Favipiravir, which is sold under the brand name Avigan, in its clinical trials.
During the summit, Duterte also sought to increase scientific cooperation in the area of vaccine and antiviral treatment research and development among Asean countries.
—Leila B. Salaverria
For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.
The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.
